1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Aisling Capital Management LP Buys Syndax Pharmaceuticals Inc, Marker Therapeutics Inc, Sells Marker Therapeutics Inc

May 11, 2020 | About:

Investment company Aisling Capital Management LP (Current Portfolio) buys Syndax Pharmaceuticals Inc, Marker Therapeutics Inc, sells Marker Therapeutics Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Aisling Capital Management LP. As of 2020Q1, Aisling Capital Management LP owns 13 stocks with a total value of $223 million. These are the details of the buys and sells.

For the details of Aisling Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/aisling+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Aisling Capital Management LP
  1. BridgeBio Pharma Inc (BBIO) - 3,989,412 shares, 51.85% of the total portfolio. Shares added by 4.01%
  2. Eidos Therapeutics Inc (EIDX) - 1,123,630 shares, 24.67% of the total portfolio.
  3. Avrobio Inc (AVRO) - 1,009,779 shares, 7.04% of the total portfolio. Shares added by 13.07%
  4. Syndax Pharmaceuticals Inc (SNDX) - 875,000 shares, 4.30% of the total portfolio. New Position
  5. Aeglea BioTherapeutics Inc (AGLE) - 1,291,151 shares, 2.70% of the total portfolio.
New Purchase: Syndax Pharmaceuticals Inc (SNDX)

Aisling Capital Management LP initiated holding in Syndax Pharmaceuticals Inc. The purchase prices were between $6.65 and $12.03, with an estimated average price of $9.37. The stock is now traded at around $18.47. The impact to a portfolio due to this purchase was 4.3%. The holding were 875,000 shares as of .

New Purchase: Marker Therapeutics Inc (MRKR)

Aisling Capital Management LP initiated holding in Marker Therapeutics Inc. The purchase prices were between $1.59 and $3.35, with an estimated average price of $2.57. The stock is now traded at around $2.48. The impact to a portfolio due to this purchase was 1.7%. The holding were 2,000,000 shares as of .

Sold Out: Marker Therapeutics Inc (GX1N)

Aisling Capital Management LP sold out a holding in Marker Therapeutics Inc. The sale prices were between $1.48 and $2.93, with an estimated average price of $2.32.



Here is the complete portfolio of Aisling Capital Management LP. Also check out:

1. Aisling Capital Management LP's Undervalued Stocks
2. Aisling Capital Management LP's Top Growth Companies, and
3. Aisling Capital Management LP's High Yield stocks
4. Stocks that Aisling Capital Management LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)